Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 613
Selected: 0
NCT IDTitle
NCT00012350Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma
NCT03543969Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
NCT01385956SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
NCT01024387AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
NCT04191187Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT00100906Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer
NCT06553885Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
NCT00617409To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
NCT01446952Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects
NCT06002126Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
NCT03712943Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
NCT03722407Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
NCT02202499Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
NCT07937423DYNAMIC Pilot Optimization Trial
NCT00006035Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00624585Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts
NCT00006376R115777 in Treating Patients With Advanced Bladder Cancer
NCT01400958Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
NCT04923542SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
NCT07007273Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
NCT00042731Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy
NCT05379933Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life
NCT03575325Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT00005615Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
NCT03176576Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population
NCT02721459XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
NCT03718650Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
NCT00786760Natural History of HPV Infection in Men: The HIM Study
NCT01754623GTX-RT in Borderline Resectable Pancreatic Cancer
NCT03501368Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
NCT02631590Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
NCT07542041Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
NCT00006031Comparison of Two Types of Biopsy in Patients With Breast Lesions
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
NCT05048316Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors
NCT03370276Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT00375024Patient Navigator Project
NCT00803010Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
NCT00005611BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
NCT01483664Communication Skills Intervention to Promote Transition Into Survivorship
NCT04766164Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults
NCT01286038Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
NCT04975152Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
NCT00948922Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
NCT01437605Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
NCT04562129IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
NCT03411031Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide
NCT00720629Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
NCT02978443A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
NCT03078348Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks